Expert Opinion on Drug Safety
Volume 23, 2024 - Issue 5
Original Research
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Bruton’s tyrosine kinase inhibitors (BTKis) single and its combination therapy
Sichun XiangThe First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China
https://orcid.org/0000-0003-1636-782XView further author information
https://orcid.org/0000-0003-1636-782XView further author information, , , , , , & Hangping GeThe First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-4718-288XView further author information
https://orcid.org/0000-0002-4718-288XView further author information show all